Cpa1
carboxypeptidase A1 (pancreatic)
CPA1; carboxypeptidase A1 (pancreatic); CPA; carboxypeptidase A1; Carboxypeptidase A1 precursor; CBPA1_HUMAN; Pancreatic carboxypeptidase A1; Procarboxypeptidase A1 pancreatic; OTTHUMP00000212514; OTTHUMP00000212515; OTTHUMP00000212518;
DDC
dopa decarboxylase (aromatic L-amino acid decarboxylase)
DDC; dopa decarboxylase (aromatic L-amino acid decarboxylase); aromatic-L-amino-acid decarboxylase; AADC;
EHMT2
EHMT2 euchromatic histone-lysine N-methyltransferase 2
EHMT2; euchromatic histone-lysine N-methyltransferase 2; BAT8, C6orf30, chromosome 6 open reading frame 30 , HLA B associated transcript 8; histone-lysine N-methyltransferase EHMT2; Em:AF134726.3; G9A; KMT1C; NG36/G9a; protein G9a; H3-K9-HMTase 3; G9A histone methyltransferase; HLA-B associated transcript 8; HLA-B-associated transcript 8; lysine N-methyltransferase 1C; ankyrin repeat-containing protein; histone H3-K9 methyltransferase 3; histone-lysine N-methyltransferase, H3 lysine-9 specific 3; BAT8; GAT8; NG36; C6orf30; FLJ35547; DKFZp686H08213;
Gad2
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
GAD2; glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa); glutamate decarboxylase 2 (pancreatic islets and brain, 65kD); glutamate decarboxylase 2; GAD65; GAD-65; 65 kDa glutamic acid decarboxylase; Glutamate decarboxylase-2 (pancreas); glutamate decarboxylase 65 kDa isoform; MGC161605; MGC161607;
LYVE1
lymphatic vessel endothelial hyaluronan receptor 1
LYVE1; lymphatic vessel endothelial hyaluronan receptor 1; Xlkd1; Lyve-1; Crsbp-1; 1200012G08Rik; lymphatic vessel endothelial hyaluronic acid receptor 1; extra cellular link domain-containing 1; lymphatic vessel endothelial HA recptor-1; lymphatic vessel endothelial HA receptor-1; extracellular link domain-containing protein 1; cell surface retention sequence binding protein-1; cell surface retention sequence-binding protein 1; HAR;
NME2
non-metastatic cells 2, protein (NM23B) expressed in
NME2; non-metastatic cells 2, protein (NM23B) expressed in; nucleoside diphosphate kinase B; NM23 H2; NDP kinase B; c-myc transcription factor; histidine protein kinase NDKB; nucleotide diphosphate kinase B; c-myc purine-binding transcription factor PUF;
NME3
non-metastatic cells 3, protein expressed in
NME3; non-metastatic cells 3, protein expressed in; nucleoside diphosphate kinase 3; DR nm23; NM23 H3; NDK 3; NDP kinase 3; NDP kinase C; nucleoside diphosphate kinase C; NDPKC; NDPK-C; NM23H3; DR-nm23; NM23-H3; c371H6.2; KIAA0516;
NME4
non-metastatic cells 4, protein expressed in
NME4; non-metastatic cells 4, protein expressed in; nucleoside diphosphate kinase, mitochondrial; nm23 H4; NM23H4; NDK; NDPKD; NDP kinase D; NDP kinase, mitochondrial; nucleoside diphosphate kinase D; NDPK-D; nm23-H4;
PDX1
pancreatic and duodenal homeobox 1
PDX1; pancreatic and duodenal homeobox 1; insulin promoter factor 1, homeodomain transcription factor , IPF1; pancreas/duodenum homeobox protein 1; IDX 1; MODY4; PDX 1; somatostatin transcription factor 1; STF 1; IPF-1; IUF-1; glucose-sensitive factor; insulin upstream factor 1; islet/duodenum homeobox-1; pancreatic-duodenal homeobox factor 1; somatostatin-transactivating factor 1; insulin promoter factor 1, homeodomain transcription factor; GSF; IPF1; IUF1; IDX-1; PDX-1; STF-1;
PNLIPRP2
pancreatic lipase-related protein 2
PNLIPRP2; pancreatic lipase-related protein 2; PLRP2; EC 3.1.1.3; Galactolipase; LIPR2_HUMAN; Pancreatic lipase; Pancreatic triacylglycerol lipase; PL; PL-RP2; PNLIP; Secretory glycoprotein GP 3; Triacylglycerol acylhydrolase;
PTI
pancreatic trypsin inhibitor
PTI; pancreatic trypsin inhibitor; Basic protease inhibitor; BPI; BPTI; aprotinin;
PKHD1
polycystic kidney and hepatic disease 1 (autosomal recessive)
PKHD1; polycystic kidney and hepatic disease 1 (autosomal recessive); FCYT; ARPKD; TIGM1; fibrocystin; tigmin; polyductin; TIG multiple domains 1; polycystic kidney and hepatic disease 1 protein; Fibrocystin; Polycystic kidney and hepatic disease 1 protein; Polyductin; Tigmin;
EHMT1
euchromatic histone-lysine N-methyltransferase 1
EHMT1; euchromatic histone-lysine N-methyltransferase 1; euchromatic histone methyltransferase 1; histone-lysine N-methyltransferase EHMT1; bA188C12.1; Eu HMTase1; FLJ12879; KIAA1876; KMT1D; H3-K9-HMTase 5; G9a like protein; G9a-like protein 1; lysine N-m;
AMY2A
amylase, alpha 2A (pancreatic)
AMY2A; amylase, alpha 2A (pancreatic); AMY2, amylase, alpha 2A; pancreatic; pancreatic alpha-amylase; 1,4 alpha D glucan glucanohydrolase; Alpha amylase; AMY2; AMY2B; Amylase, alpha 2A; Amylase, pancreatic, A; Glycogenase; PA; alpha-amylase; OTTHUMP00000012694; found in the pancreas; pancreatic amylase 2A; pancreatic amylase alpha 2A; amylase, pancreatic, alpha-2A; 1,4-alpha-D-glucan glucanohydrolase;
AMY2B
amylase, alpha 2B (pancreatic)
AMY2B; amylase, alpha 2B (pancreatic); AMY2, amylase, alpha 2B; pancreatic; alpha-amylase 2B; 1; 1,4-alpha-D-glucan glucanohydrolase; 1,4-alpha-D-glucan glucanohydrolase 2B; 4-alpha-D-glucan glucanohydrolase 2B; Alpha-amylase carcinoid; AMY2; AMY2B_HUMAN; amylase, alpha 2B; Amylase, pancreatic, alpha-2B; Carcinoid alpha-amylase; EC 3.2.1.1; Glycogenase; OTTHUMP00000012696;
CLPS
colipase, pancreatic
CLPS; colipase, pancreatic; colipase; Colipase pancreatic; Pancreatic colipase preproprotein; OTTHUMP00000016271;
NME6
non-metastatic cells 6, protein expressed in (nucleoside-diphosphate kinase)
NME6; non-metastatic cells 6, protein expressed in (nucleoside-diphosphate kinase); nucleoside diphosphate kinase 6; IPIA ALPHA; NM23 H6; NDP kinase 6; inhibitor of p53-induced apoptosis-alpha; NDK 6; NM23-H6; IPIA-ALPHA;
PNLIP
pancreatic lipase
PNLIP; pancreatic lipase; PL; PTL; pancreatic triacylglycerol lipase; OTTHUMP00000020564; triacylglycerol acylhydrolase; Lipase;
RNASE1
ribonuclease, RNase A family, 1 (pancreatic)
RNASE1; RNS1; ribonuclease pancreatic; RNase 1; RNase A; ribonuclease A (pancreatic);
NME5
non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase)
NME5; non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase); nucleoside diphosphate kinase homolog 5; nm23 H5; radial spoke 23 homolog (Chlamydomonas); RSPH23; NDK-H 5; IPIA-beta; NDP kinase homolog 5; radial spoke 23 homolog; testi;
NME7
non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase)
NME7; non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase); nucleoside diphosphate kinase 7; FLJ37194; NM23 H7; NDK 7; NDP kinase 7; nucleoside-diphosphate kinase 7; MN23H7; nm23-H7;
PKHD1L1
polycystic kidney and hepatic disease 1 (autosomal recessive)-like 1
PKHD1L1;polycystic kidney and hepatic disease 1 (autosomal recessive)-like 1;fibrocystin-L;fibrocystin L;PKHD1-like protein 1;polycystic kidney and hepatic disease-like 1;polycystic kidney and hepatic disease 1-like protein 1;PKHDL1;DKFZp586C1021;
PNLIPRP1
pancreatic lipase-related protein 1
PNLIPRP1; pancreatic lipase-related protein 1; PLRP1; Pancreatic lipase related protein 1; PL-RP1; OTTHUMP00000020567; OTTHUMP00000230058; OTTHUMP00000230064;
PPY
pancreatic polypeptide
PPY; pancreatic polypeptide; pancreatic prohormone; PP; pancreatic polypeptide Y; PNP; Obinepitide; Pancreatic prohormone; Pancreatic polypeptide Y; PP; Pancreatic Polypeptide; Pancreatic hormone;
ATIC
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
ATIC; 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase; bifunctional purine biosynthesis protein PURH; AICARFT; IMPCHASE; phosphoribosylaminoimidazolecarboxamide formyltransferase/IMP cyclohydrolase; PURH; AICARFT/IMPCHAS;
AMY2
amylase, alpha 2B (pancreatic)
AMY2; amylase, alpha 2B (pancreatic); pancreatic alpha-amylase; 1 4 alpha D glucan glucanohydrolase; Alpha amylase 2B; Alpha amylase carcinoid; Amylase alpha 2A; pancreatic; PA; alpha-amylase; 1,4-alpha-D-glucan glucanohydrolase; AMY2B;
PPYR1
pancreatic polypeptide receptor 1
PPYR1; pancreatic polypeptide receptor 1; neuropeptide Y receptor type 4; NPY4R; PP1; Y4; MGC116897; NPY4 R; PP 1; PPY R1; PPYR 1; NPY4-R;
HEPACAM
hepatic and glial cell adhesion molecule
HEPACAM; hepatic and glial cell adhesion molecule; hepatocyte cell adhesion molecule; FLJ25530; glial cell adhesion molecule; GLIALCAM; protein hepaCAM; MLC2A; MLC2B;
PNLIPRP3
pancreatic lipase-related protein 3
PNLIPRP3;pancreatic lipase-related protein 3;23492;ENSG00000203837;10q25.3;pancreatic lipase-related protein 3;pancreatic lipase-related protein 3;PL-RP3;EC 3.1.1.3;
SLC16A10
solute carrier family 16, member 10 (aromatic amino acid transporter)
SLC16A10;solute carrier family 16, member 10 (aromatic amino acid transporter);17027;ENSG00000112394;TAT1;PRO0813;6q21-q22;monocarboxylate transporter 10;monocarboxylate transporter 10;MCT 10;T-type amino acid transporter 1;aromatic amino acid transporter 1;solute carrier family 16 member 10;solute carrier family 16 (monocarboxylic acid transporters), member 10;
PPDPF
PPDPF pancreatic progenitor cell differentiation and proliferation factor homolog (zebrafish) [ Homo sapiens ]
pancreatic progenitor cell differentiation and proliferation factor homolog(zebrafish); Exocrine differentiation and proliferation factor; C20orf149; hromosome 20 open reading frame 149; dJ697K14.9; pancreatic progenitor cell differentiation and proliferation factor; exdpf; EXPDF;
In Face of Pancreatic Cancer
Gene Database Associated with Pancreatic Cancer for Your Reference Whenever talk about pancreatic cancer, people would feel scared. In China, pancreatic cancer is called as the king of all cancers due to its poor prognosis and short survival time. In developed countries, it is also a very trouble...
CD44, CD47 and MET Have been Found Related to Initiation of Metastatic Cancer Cells
Circulating tumor cells (CTCs) are now treated as a biomarker for prognosis and people think the CTCs are connected to cancer metastasis. But there is no clear clue to clarify how CTCs affect patients. Some scientists thought only few CTCs will form secondary tumor in different organs as the metast...
2013 Conference in Applied Bioinformatics & Public Health Microbiology
When May 15, 2013 to May 17, 2013 Where Moller Centre, Churchill College, Cambridge, UK Introduction Till now, the conference registration and abstract submission has closed. But the conference indeed accepts waitlist. Organized by Wellcome Trust, the conference aims to recent ...
Systematic Evolution of Ligands by Exponential Enrichment (SELEX)
The Systematic Evolution of Ligands by Exponential Enrichment (SELEX) is a combinatorial chemical technology developed in the 1990s. Using this technique, aptamers with high specific affinity for the target substance can be screened from a library of random single-stranded nucleic acid sequences, an...
